Coagulation

A unique portfolio of products to assist with the identification of deficiencies in clotting factors and detection of antibodies involved in thrombosis and thrombocytopenia, providing support for the diagnosis of Heparin-Induced Thrombocytopenia (HIT) and Thrombotic Thrombocytopenic Purpura (TTP).

Explore Our Products

PF4 Enhanced^® and PF4 IgG Assay

Detect harmful antibodies that cause Heparin Induced Thrombocytopenia (HIT).

View Product

PF4 Enhanced^® and PF4 IgG Assay

View Product

ATS-13^® Activity Assay

What is your testing algorithm for patients suspected of having thrombotic thrombocytopenic purpura (TTP)?

View Product

ATS-13^® Activity Assay

View Product

Labs We Serve

A leader in transfusion and transplantation diagnostics, Werfen is proud to partner with thousands of hospitals, clinical laboratories, reference laboratories and donor centers across the globe. Since 1982, we have been innovating on behalf of our customers, laboratories just like yours.

Select your lab type:

Upcoming Events,
Webinars & Workshops

View Events Calendar

Upcoming Event

From Phenotype to Pathology

When

July 15th 2025

Where

—

View

Keep Up With Us

View All News & Blogs

News & Blogs

Werfen acquires Omixon

Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics. The acquisition expands Werfen’s portfolio of transplant diagnostics solutions for...

Continue Reading View All